Connect
MJA
MJA

The rising cost of vitamin D testing in Australia: time to establish guidelines for testing

Kellie L Bilinski and Steven C Boyages
Med J Aust 2012; 197 (2): . || doi: 10.5694/mja12.10561
Published online: 16 July 2012

To the Editor: A rising awareness of the prevalence of 25-hydroxyvitamin D (25OHD) deficiency over the past decade is likely to have led to a surge in the number of individuals who undergo 25OHD testing.1 United States data indicate that testing for 25OHD has increased by 80%–90% annually,2 yet there are no reports that investigate the cost of 25OHD testing in Australia. We analysed the Medicare Benefits Schedule (MBS) to determine the economic impact of vitamin D testing in Australia from 1 January 2000 to 31 December 2010.


  • 1 Westmead Breast Cancer Institute, Sydney, NSW.
  • 2 eHealth NSW Initiative, Sydney, NSW.


Correspondence: Kellie.Bilinski@bci.org.au

Competing interests:

No relevant disclosures.

  • 1. Boyages S, Bilinski K. Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clin Endocrinol (Oxf) 2012; Apr 3 [Epub]. doi: 10.1111/j.1365-2265.2012.04398.x
  • 2. Singh RJ. Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? [Letter]. Clin Chem 2008; 54: 221-223.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.